Leisure Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-145
| Closed | -$5K | – | 137 |
|
|
2018
Q4 | $5K | Sell |
145
-13
| -8% | -$448 | ﹤0.01% | 126 |
|
|
2018
Q3 | $12K | Buy |
+158
| New | +$12K | 0.01% | 129 |
|
|
2018
Q2 | – | Sell |
-161
| Closed | -$14K | – | 146 |
|
|
2018
Q1 | $14K | Sell |
161
-3
| -2% | -$261 | 0.01% | 143 |
|
|
2017
Q4 | $122K | Buy |
164
+4
| +3% | +$2.98K | 0.1% | 110 |
|
|
2017
Q3 | $46K | Sell |
160
-3
| -2% | -$863 | 0.04% | 106 |
|
|
2017
Q2 | $42K | Sell |
163
-5
| -3% | -$1.29K | 0.04% | 110 |
|
|
2017
Q1 | $56K | Sell |
168
-5
| -3% | -$1.67K | 0.05% | 104 |
|
|
2016
Q4 | $104K | Buy |
173
+3
| +2% | +$1.8K | 0.09% | 103 |
|
|
2016
Q3 | $192K | Sell |
170
-1
| -0.6% | -$1.13K | 0.18% | 93 |
|
|
2016
Q2 | $187K | Hold |
171
| – | – | 0.18% | 92 |
|
|
2016
Q1 | $219K | Hold |
171
| – | – | 0.22% | 83 |
|
|
2015
Q4 | $419K | Buy |
171
+5
| +3% | +$12.3K | 0.38% | 65 |
|
|
2015
Q3 | $184K | Buy |
166
+5
| +3% | +$5.54K | 0.2% | 80 |
|
|
2015
Q2 | $162K | Buy |
161
+9
| +6% | +$9.06K | 0.16% | 86 |
|
|
2015
Q1 | $154K | Buy |
+152
| New | +$154K | 0.15% | 85 |
|